oxazolidinones

Pharmacology
Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
Sandrine Lemaire, Klaudia Kosowska-Shick, Peter C. Appelbaum, Gunther Verween, Paul M. Tulkens, Françoise Van Bambeke
Susceptibility
Comparative Activities of TR-700 (Torezolid) against Staphylococcal Blood Isolates Collected in Spain
Carmen Betriu, Gracia Morales, Icíar Rodríguez-Avial, Esther Culebras, María Gómez, Fátima López-Fabal, Juan J. Picazo
Susceptibility
Antistaphylococcal Activity of ACHN-490 Tested Alone and in Combination with Other Agents by Time-Kill Assay
Gengrong Lin, Lois M. Ednie, Peter C. Appelbaum
Susceptibility
Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges
Steven D. Brown, Maria M. Traczewski
Pharmacology
Activity of Linezolid in an In Vitro Pharmacokinetic-Pharmacodynamic Model Using Different Dosages and Staphylococcus aureus and Enterococcus faecalis Strains with and without a Hypermutator Phenotype
Boubakar B. Ba, Corinne Arpin, Branly Bikie Bi Nso, Véronique Dubois, Marie-Claude Saux, Claudine Quentin
Mechanisms of Resistance
Resistance to Linezolid in a Porcine Clostridium perfringens Strain Carrying a Mutation in the rplD Gene Encoding the Ribosomal Protein L4
Christina S. Hölzel, Katrin S. Harms, Karin Schwaiger, Johann Bauer
Mechanisms of Resistance
Polyphyletic Emergence of Linezolid-Resistant Staphylococci in the United States
Agnes Wong, Shilpa P. Reddy, Davida S. Smyth, Maria E. Aguero-Rosenfeld, George Sakoulas, D. Ashley Robinson
Experimental Therapeutics
Ceftobiprole Is Superior to Vancomycin, Daptomycin, and Linezolid for Treatment of Experimental Endocarditis in Rabbits Caused by Methicillin-Resistant Staphylococcus aureus
P. Tattevin, L. Basuino, D. Bauer, B. A. Diep, H. F. Chambers
Mechanisms of Resistance
Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
Jeffrey B. Locke, Mark Hilgers, Karen Joy Shaw
Mechanisms of Resistance
Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin
Jeffrey B. Locke, Mark Hilgers, Karen Joy Shaw

Pages